Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT04586894
Eligibility Criteria:
Inclusion Criteria:
\- prescribed treatment by immune checkpoint inhibitors (ICI) for cancer
Exclusion Criteria:
* previous treatment by any ICI
* any contraindication to cardiac resonance magnetic imaging
* contraindication to gadoteric acid, meglumin or any gadolinium-based contrast agent
* pace maker or automated implantable defibrilator
* pregnancy, breastfeeding
* women of childbearing potential who do not use one of the following methods of birth control: hormonal contraception or intrauterine device or bilateral tubal occlusion
* patient under legal protection
* renal failure defined by creatinine clearance \<30ml/min/m² (CKD-EPI)
* current participation or exclusion period of another interventional clinical study
Exclusion Criteria for ancillary studies:
\- hemoglobinemia \< 9 g/dl
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04586894
Study Brief:
Protocol Section:
NCT04586894